ArticleFrontiers in immunology2026
Vascular, inflammatory and immune factors associated with acute ischemic events in Takayasu arteritis: a 10-year retrospective matched case-control study.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Acute ischemic events (AIE) constitute life-threatening complications of Takayasu arteritis (TAK). This study aimed to identify vascular, inflammatory and immune factors associated with concurrent AIE in TAK patients. Methods: We conducted a 10-year retrospective 1:2 matched case-control study including TAK patients without exposure to glucocorticoids, immunosuppressants, or antithrombotic agents for at least 3 months. Clinical characteristics, disease activity, inflammatory markers, and lymphocyte subsets were compared between patients with and without AIE. Three sequential multivariable logistic regression models were constructed to identify variables independently associated with AIE. Model discrimination was evaluated using receiver operating characteristic (ROC) analysis with 1000-bootstrap internal validation, while calibration and decision curve analysis (DCA) were performed as exploratory within-sample assessments. Results: Thirty-seven patients with AIE and 74 matched TAK control without AIE were included. The mean age at TAK onset in the AIE group was 34.92 ± 10.83 years (range: 16-58 years). Conventional markers including ESR, CRP and homocysteine showed no independent correlation with AIE. Patients with AIE presented substantially higher frequencies of coronary, anterior cerebral, middle cerebral, and femoral artery stenosis, alongside significantly elevated ITAS-2010 scores, serum IgA and IL-6 levels, and peripheral Th cell counts (all Conclusions: Specific vascular stenosis, high disease activity, elevated serum IgA and IL-6 levels, and increased peripheral Th cell counts are independently associated with AIE in TAK. These findings provide additional insight into the vascular, inflammatory, and immune characteristics accompanying ischemic complications in TAK and warrant confirmation in prospective multicenter studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.